Actinomycin-D for methotrexate-resistant low-risk gestational trophoblastic neoplasia (GTN)

被引：0
|
作者：
Lurain, J. [1 ]
Schink, J. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Prentice Womens Hosp, Chicago, IL 60611 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
159
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [31] Treatment of low-risk gestational trophoblastic neoplasia
    Winter, Matthew C.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2021, 74 : 67 - 80
  • [32] The diagnostics and treatment of low-risk gestational trophoblastic neoplasia (GTN): 42-year experience
    Fulop, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Lahm, Erika
    Vegh, Gyorgy
    Demeter, Janos
    Papai, Zsuzsanna
    Berkowitz, Ross S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1159 - 1165
  • [33] Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Aghajanian, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 786 - +
  • [34] Comparison of Cost-Effectiveness Between Actinomycin D Versus Methotrexate-Folinic Acid in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Lertkhachonsuk, Arb-aroon
    Hanvoravongchai, Piya
    JOURNAL OF REPRODUCTIVE MEDICINE, 2016, 61 (5-6) : 230 - 234
  • [35] TREATMENT OF HIGH-RISK GESTATIONAL TROPHOBLASTIC DISEASE WITH METHOTREXATE, ACTINOMYCIN-D, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
    LURAIN, JR
    BREWER, JI
    OBSTETRICS AND GYNECOLOGY, 1985, 65 (06): : 830 - 836
  • [36] Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia A Randomized Controlled Trial
    Lertkhachonsuk, Arb-aroon
    Israngura, Nathpong
    Wilailak, Sarikapan
    Tangtrakul, Somsak
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 985 - 988
  • [37] Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women
    Hartmann Uberti, Elza Maria
    Fajardo, Maria do Carmo
    Vieira da Cunha, Adriana Gerhardt
    Frota, Sirlene Soares
    Braga, Antonio
    Koehler Ayub, Antonio Celso
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2015, 37 (06): : 258 - 265
  • [38] Comparison of pulsed actinomycin D and 5-day actinomycin D as first-line chemotherapy for low-risk gestational trophoblastic neoplasia
    Mu, Xiyan
    Song, Liang
    Li, Qingli
    Yin, Rutie
    Zhao, Xia
    Wang, Danqing
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 (02) : 225 - 231
  • [39] Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia
    Cyriac, Sanju
    Rajendranath, Rejiv
    Sridevi, Veluswami
    Sagar, Tenali G.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (01) : 37 - 39
  • [40] Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia
    Chan, Karen K. L.
    Huang, Yong
    Tam, Kar Fai
    Tse, Ka Yu
    Ngan, Hextan Y. S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (05) : 1282 - 1286
12345